Hypothalamic mechanisms in cachexia

Physiology and Behavior

Volumn 100, Issue 5, 2010, Pages 478-489

  Grossberg, Aaron J ^a   Scarlett, Jarrad M ^a   Marks, Daniel L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Behavior; Cachexia; Cytokines; Feeding; Hypothalamus; Inflammation; Melanocortin

Indexed keywords

INTERLEUKIN 1BETA; MELANOCORTIN; NEUROHORMONE; NEUROPEPTIDE Y;

BRAIN FUNCTION; BRAIN REGION; CACHEXIA; CHRONIC DISEASE; CYTOKINE PRODUCTION; HUMAN; HYPOTHALAMUS; ILLNESS BEHAVIOR; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; STEREOTYPY;

EID: 77953810296     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.03.011     Document Type: Review

References (203)

1. Hart B.L. The behavior of sick animals. Vet Clin North Am Small Anim Pract 1991, 21:225-237.
2. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988, 12:123-137.
3. Kluger M.J., Kozak W., Conn C.A., Leon L.R., Soszynski D. The adaptive value of fever. Infect Dis Clin North Am 1996, 10:1-20.
4. Kluger M.J. The evolution and adaptive value of fever. Am Sci 1978, 66:38-43.
5. Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol 2009, 21:63-67.
6. Murray M.J., Murray A.B. Anorexia of infection as a mechanism of host defense. Am J Clin Nutr 1979, 32:593-596.
7. Katz A.M., Katz P.B. Diseases of the heart in the works of Hippokrates. Br Heart J 1962, 24:257-264.
8. Tisdale M.J. Biology of cachexia. J Natl Cancer Inst 1997, 89:1763-1773.
9. Larkin M. Thwarting the dwindling progression of cachexia. Lancet 1998, 351:1336.
10. Loprinzi C.L., Schaid D.J., Dose A.M., Burnham N.L., Jensen M.D. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993, 11:152-154.
11. Carroll P.V. Treatment with growth hormone and insulin-like growth factor-I in critical illness. Best Pract Res Clin Endocrinol Metab 2001, 15:435-451.
12. Della Cuna G.R., Pellegrini A., Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 1989, 25:1817-1821.
13. Crown A.L., Cottle K., Lightman S.L., Falk S., Mohamed-Ali V., Armstrong L., et al. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?. Clin Endocrinol (Oxf) 2002, 56:723-733.
14. Deboer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008, 149:827-835.
15. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007, 148:3004-3012.
16. Garcia J.M., Polvino W.J. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 2007, 12:594-600.
17. Markison S., Foster A.C., Chen C., Brookhart G.B., Hesse A., Hoare S.R., et al. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology 2005, 146:2766-2773.
18. Marks D.L., Ling N., Cone R.D. Role of the central melanocortin system in cachexia. Cancer Res 2001, 61:1432-1438.
19. Wisse B.E., Frayo R.S., Schwartz M.W., Cummings D.E. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001, 142:3292-3301.
20. Evans W.J., Morley J.E., Argiles J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
21. Cavaillon J.M., Haeffner-Cavaillon N. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine 1990, 2:313-329.
22. Hillhouse E.W., Mosley K. Peripheral endotoxin induces hypothalamic immunoreactive interleukin-1 beta in the rat. Br J Pharmacol 1993, 109:289-290.
23. van Dam A.M., Bauer J., Tilders F.J., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995, 65:815-826.
24. van Dam A.M., Poole S., Schultzberg M., Zavala F., Tilders F.J. Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann N Y Acad Sci 1998, 840:128-138.
25. Baile C.A., Naylor J., McLaughlin C.L., Catanzaro C.A. Endotoxin-elicited fever and anorexia and elfazepam-stimulated feeding in sheep. Physiol Behav 1981, 27:271-277.
26. Plata-Salamán C.R., Ilyin S.E., Gayle D., Flynn M.C. Gram-negative and gram-positive bacterial products induce differential cytokine profiles in the brain: analysis using an integrative molecular-behavioral in vivo model. Int J Mol Med 1998, 1:387-397.
27. Anker S.D., Ponikowski P.P., Clark A.L., Leyva F., Rauchhaus M., Kemp M., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999, 20:683-693.
28. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
29. Deans C., Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005, 8:265-269.
30. Scott H.R., McMillan D.C., Crilly A., McArdle C.S., Milroy R. The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 1996, 73:1560-1562.
31. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., Ffrench-Mullen J.M.H. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Phys Behav 1996, 60:867-875.
32. Chesnokova V., Melmed S. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 2000, 141:4032-4040.
33. Bendtzen K., Baek L., Berild D., Hasselbach H., Dinarello C.A., Wolff S.M. Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever. N Engl J Med 1984, 310:596.
34. Krueger J.M., Fang J., Taishi P., Chen Z., Kushikata T., Gardi J. Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann N Y Acad Sci 1998, 856:148-159.
35. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20years of progress and discovery. Brain Behav Immun 2007, 21:374-383.
36. Sonti G., Ilyin S.E., Plata-Salaman C.R. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 1996, 270:R1394-R1402.
37. Plata-Salaman C.R. Anorexia induced by activators of the signal transducer gp 130. Neuroreport 1996, 7:841-844.
38. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003, 5:87-90.
39. Langen R.C., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. Faseb J 2001, 15:1169-1180.
40. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004, 119:285-298.
41. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
42. Baracos V., Rodemann H.P., Dinarello C.A., Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983, 308:553-558.
43. Chida D., Osaka T., Hashimoto O., Iwakura Y. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 2006, 55:971-977.
44. Garcia M.C., Wernstedt I., Berndtsson A., Enge M., Bell M., Hultgren O., et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 2006, 55:1205-1213.
45. Somm E., Henrichot E., Pernin A., Juge-Aubry C.E., Muzzin P., Dayer J.M., et al. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 2005, 54:3503-3509.
46. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
47. Plata-Salaman C.R. Immunoregulators in the nervous system. Neurosci Biobehav Rev 1991, 15:185-215.
48. Wang Z., Ren S.G., Melmed S. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 1996, 137:2947-2953.
49. Dinarello C.A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991, 163:1177-1184.
50. Turrin N.P., Plata-Salaman C.R. Cytokine-cytokine interactions and the brain. Brain Res Bull 2000, 51:3-9.
51. Grossberg A.J., Scarlett J.M., Zhu X., Bowe D.D., Batra A.K., Braun T.P., et al. Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. Endocrinology 2010, 151:606-616.
52. Wisse B.E., Ogimoto K., Tang J., Harris M.K., Raines E.W., Schwartz M.W. Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology 2007, 148:5230-5237.
53. Broback J.R., Tepperman J., Long C.N.H. Experimental hypothalamic hyperphagia in the albino rat. Yale J Biol Med 1943, 15:831-853.
54. Hotheriogtoa A.W., Ranson S.W. Hypothalamic lesions and adiposity in the rat. Anat Rec 1940, 78:149-172.
55. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 1999, 73:309-321.
56. Eriksson C., Nobel S., Winblad B., Schultzberg M. Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine 2000, 12:423-431.
57. Gayle D., Ilyin S.E., Flynn M.C., Plata-Salaman C.R. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res 1998, 795:77-86.
58. Laye S., Gheusi G., Cremona S., Combe C., Kelly K., Dantzer R., et al. Endogenous brain IL-1 mediates the response to peripheral LPS. Am J Phys Reg Integr Comp Physiol 2000, 279:R93-R98.
59. Takao T., Hashimoto K., De Souza E.B. Modulation of interleukin-1 receptors in the neuro-endocrine-immune axis. Int J Dev Neurosci 1995, 13:167-178.
60. Ericsson A., C.L., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 1995, 361:681-698.
61. Nadeau S., Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999, 93:1449-1464.
62. Utsuyama M., Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp Gerontol 2002, 37:411-420.
63. Yamakuni H., Minami M., Satoh M. Localization of mRNA for leukemia inhibitory factor receptor in the adult rat brain. J Neuroimmunol 1996, 70:45-53.
64. Wan W., Janz L., Vriend C.Y., Sorensen C.M., Greenberg A.H., Nance D.M. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res Bull 1993, 32:581-587.
65. Herkenham M., Lee H.Y., Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J Comp Neurol 1998, 400:175-196.
66. Elmquist J.K., Scammell T.E., Jacobsen C.D., Saper C.B. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 1996, 371:85-103.
67. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999, 22:221-232.
68. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
69. Broberger C., Johansen J., Johansson C., Schalling M., Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 95:15043-15048.
70. Benoit S., Schwartz M., Baskin D., Woods S.C., Seeley R.J. CNS melanocortin system involvement in the regulation of food intake. Horm Behav 2000, 37:299-305.
71. Jegou S., Boutelet I., Vaudry H., Articles R. Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol Jun 2000, 12(6):501-505.
72. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994, 8:1298-1308.
73. Xia Y., Wikberg J.E.S. Postnatal expression of melanocortin-3 receptor in rat diencephalon and mesencephalon. Neuropharmacology 1997, 36:217-224.
74. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
75. Garfield A.S., Lam D.D., Marston O.J., Przydzial M.J., Heisler L.K. Role of central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab 2009, 20:203-215.
76. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
77. Hagan M.M., Rushing P.A., Pritchard L.M., Schwartz M.W., Strack A.M., Van Der Ploeg L.H., et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 2000, 279:R47-R52.
78. Woods S.C., Seeley R.J., Porte D., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science 1998, 280:1378-1382.
79. Qian S., Chen H., Weingarth D., Trumbauer M.E., Novi D.E., Guan X., et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 2002, 22:5027-5035.
80. Cheung W., Yu P.X., Little B.M., Cone R.D., Marks D.L., Mak R.H. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005, 115:1659-1665.
81. Marks D.L., Butler A.A., Turner R., Brookhart G., Cone R.D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 2003, 144:1513-1523.
82. Sartin J.L., Marks D.L., McMahon C.D., Daniel J.A., Levasseur P., Wagner C.G., et al. Central role of the melanocortin-4 receptors in appetite regulation after endotoxin. J Anim Sci 2008, 86:2557-2567.
83. Inui A. Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?. Mol Med Today 1999, 5:79-85.
84. McCarthy H.D., Crowder R.E., Dryden S., Williams G. Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations. Eur J Pharmacol 1994, 265:99-102.
85. Chance W.T., Balasubramaniam A., Thompson H., Mohapatra B., Ramo J., Fischer J.E. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides 1996, 17:797-801.
86. ANAND B.K., BROBECK J.R. Localization of a "feeding center" in the hypothalamus of the rat. Proc Soc Exp Biol Med 1951, 77:323-324.
87. Hetherington A.W., R.S. Hypothalamic lesions and adiposity in the rat. Anat Rec 1940, 78:149-172.
88. Coleman D.L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973, 9:294-298.
89. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
90. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
91. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997, 138:4489-4492.
92. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Morgan P.J., et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996, 8:733-735.
93. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 22:775-786.
94. Schwartz M.W., Peskind E., Raskind M., Boyko E.J., Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-593.
95. Ciofi P., Garret M., Lapirot O., Lafon P., Loyens A., Prévot V., et al. Brain-Endocrine Interactions: A Microvascular Route in the Mediobasal Hypothalamus. Endocrinology 2009, 150:5509-5519.
96. Banks W.A. Blood-brain barrier and energy balance. Obesity (Silver Spring) 2006, 14(Suppl 5):234S-237S.
97. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994, 179:53-56.
98. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991, 259:988-996.
99. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993, 47:169-176.
100. Pan W., Yu C., Hsuchou H., Zhang Y., Kastin A.J. Neuroinflammation facilitates LIF entry into brain: role of TNF. Am J Physiol Cell Physiol 2008, 294:C1436-C1442.
101. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 2002, 283:R862-R868.
102. Tizard I. Sickness behavior, its mechanisms and significance. Anim Health Res Rev 2008, 9:87-99.
103. Engblom D., Saha S., Engström L., Westman M., Audoly L.P., Jakobsson P.-J., et al. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 2003, 6:1137-1138.
104. Pecchi E., Dallaporta M., Thirion S., Salvat C., Berenbaum F., Jean A., et al. Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-induced anorexia. Physiol Genomics 2006, 25:485-492.
105. Jakobsson P.J., Thorén S., Morgenstern R., Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999, 96:7220-7225.
106. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000, 275:32783-32792.
107. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., et al. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 2001, 21:2669-2677.
108. Dallaporta M., Pecchi E., Jacques C., Berenbaum F., Jean A., Thirion S., et al. c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1). Brain Behav Immun 2007, 21:1109-1121.
109. Pecchi E., Dallaporta M., Jean A., Thirion S., Troadec J.D. mPGES-1 knock-out mice are resistant to cancer-induced anorexia despite the absence of central mPGES-1 up-regulation in wild-type anorexic mice. J Neuroimmunol 2008, 199:104-114.
110. Serrats J., Schiltz J.C., García-Bueno B., van Rooijen N., Reyes T.M., Sawchenko P.E. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 2010, 65:94-106.
111. García-Bueno B., Serrats J., Sawchenko P.E. Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J Neurosci 2009, 29:12970-12981.
112. Ching S., Zhang H., Belevych N., He L., Lai W., Pu X.-A., et al. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci 2007, 27:10476-10486.
113. Hansen M.K., Taishi P., Chen Z., Krueger J.M. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci 1998, 18:2247-2253.
114. Layé S., Bluthé R.M., Kent S., Combe C., Médina C., Parnet P., et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol 1995, 268:R1327-R1331.
115. Konsman J.P., Luheshi G.N., Bluthé R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci 2000, 12:4434-4446.
116. Luheshi G.N., Bluthé R.M., Rushforth D., Mulcahy N., Konsman J.P., Goldbach M., et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci Basic Clin 2000, 85:127-132.
117. Bret-Dibat J.L., Bluthé R.M., Kent S., Kelley K.W., Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 1995, 9:242-246.
118. Porter M.H., Hrupka B.J., Langhans W., Schwartz G.J. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am J Physiol 1998, 275:R384-R389.
119. Ericsson A., Kovács K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 1994, 14:897-913.
120. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 1982, 257:275-325.
121. Sergeyev V., Broberger C., Hokfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res 2001, 90:93-100.
122. Endo M., Masaki T., Seike M., Yoshimatsu H. Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. Regul Pept 2007, 140:94-100.
123. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem 2000, 74:457-471.
124. Giulian D., Tapscott M.J. Immunoregulation of cells within the central nervous system. Brain Behav Immun 1988, 2:352-358.
125. Higgins G.A., Olschowka J.A. Induction of interleukin-1 beta mRNA in adult rat brain. Brain Res Mol Brain Res 1991, 9:143-148.
126. Stalder A.K., Campbell I.L. Simultaneous analysis of multiple cytokine receptor mRNAs by RNase protection assay in LPS-induced endotoxemia. Lymphokine Cytokine Res 1994, 13:107-112.
127. Turrin N.P., Ilyin S.E., Gayle D.A., Plata-Salaman C.R., Ramos E.J., Laviano A., et al. Interleukin-1beta system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care 2004, 7:419-426.
128. Webb A.C., Collins K.L., Auron P.E., Eddy R.L., Nakai H., Byers M.G., et al. Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Res 1986, 5:77-85.
129. Thornberry N.A., Molineaux S.M. Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci 1995, 4:3-12.
130. Hirsch E., Irikura V.M., Paul S.M., Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A 1996, 93:11008-11013.
131. Boraschi D., Tagliabue A. The interleukin-1 receptor family. Vitam Horm 2006, 74:229-254.
132. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 1995, 361:681-698.
133. Parnet P., Kelley K.W., Bluthe R.M., Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol 2002, 125:5-14.
134. Ilyin S.E., Gayle D., Flynn M.C., Plata-Salaman C.R. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res Bull 1998, 45:507-515.
135. Gayle D., Ilyin S.E., Plata-Salaman C.R. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res Bull 1997, 44:311-317.
136. Kluger M.J. Fever: role of pyrogens and cryogens. Physiol Rev 1991, 71:93-127.
137. Hori T., Shibata M., Nakashima T., Yamasaki M., Asami A., Asami T., et al. Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothalamic neurons. Brain Res Bull 1988, 20:75-82.
138. Li S., Ballou L.R., Morham S.G., Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res 2001, 910:163-173.
139. Katsuura G., Gottschall P.E., Dahl R.R., Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology 1988, 122:1773-1779.
140. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav Immun 2001, 15:7-24.
141. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., et al. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A 1992, 89:9117-9120.
142. Shimizu H., Uehara Y., Shimomura Y., Kobayashi I. Central administration of ibuprofen failed to block the anorexia induced by interleukin-1. Eur J Pharmacol 1991, 195:281-284.
143. Shimomura Y., Inukai T., Kuwabara S., Shimizu H., Takahashi M., Sato N., et al. Both cyclooxygenase and lipoxygenase inhibitor partially restore the anorexia by interleukin-1 beta. Life Sci 1992, 51:1419-1426.
144. Reyes T.M., Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J Neurosci 2002, 22:5091-5099.
145. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., et al. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 2007, 148:4217-4225.
146. Scarlett J.M., Zhu X., Enriori P.J., Bowe D.D., Batra A.K., Levasseur P.R., et al. Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology 2008, 149:4837-4845.
147. Bergen HT, Mizuno TM, Taylor J, Mobbs CV Hyperphagia and weight gain after gold-thio-glucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. Endocrinology 1998, 139:4483-4488.
148. Broberger C., Johansson C., Schalling M., Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 95:15043-15048.
149. Hill A.G., Jacobson L., Gonzalez J., Rounds J., Majzoub J.A., Wilmore D.W. Chronic central nervous system exposure to interleukin-1 beta causes catabolism in the rat. Am J Physiol 1996, 271:R1142-R1148.
150. Gearing D.P., Gough N.M., King J.A., Hilton D.J., Nicola N.A., Simpson R.J., et al. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 1987, 6:3995-4002.
151. Owczarek C.M., Layton M.J., Robb L.G., Nicola N.A., Begley C.G. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice. J Biol Chem 1996, 271:5495-5504.
152. Aikawa J., Sato E., Kyuwa S., Sato E., Sasai K., Shiota K., et al. Asparagine-linked glycosylation of the rat leukemia inhibitory factor expressed by simian COS7 cells. Biosci Biotechnol Biochem 1998, 62:1318-1325.
153. Sasai K., Aikawa J.I., Saburi S., Tojo H., Tanaka S., Ogawa T., et al. Functions of the N-glycans of rat leukemia inhibitory factor expressed in Chinese hamster ovary cells. J Biochem 1998, 124:999-1003.
154. Auernhammer C.J., Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 2000, 21:313-345.
155. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819.
156. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20.
157. Febbraio M.A. gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest 2007, 117:841-849.
158. Kievit P., Howard J.K., Badman M.K., Balthasar N., Coppari R., Mori H., et al. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006, 4:123-132.
159. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W.K., Wang Y., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
160. Janoschek R., Plum L., Koch L., Münzberg H., Diano S., Shanabrough M., et al. gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor. Proc Natl Acad Sci USA 2006, 103:10707-10712.
161. Prima V., Tennant M., Gorbatyuk O.S., Muzyczka N., Scarpace P.J., Zolotukhin S. Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression. Endocrinology 2004, 145:2035-2045.
162. Benomar Y., Berthou F., Vacher C.-M., Bailleux V., Gertler A., Djiane J., et al. Leptin but not ciliary neurotrophic factor (CNTF) induces phosphotyrosine phosphatase-1B expression in human neuronal cells (SH-SY5Y): putative explanation of CNTF efficacy in leptin-resistant state. Endocrinology 2009, 150:1182-1191.
163. Ropelle E.R., Rocha G.Z., Cintra D.E., Prada P.O., Pauli J.R., Picardi P.K., et al. Key phosphatase in cancer-induced anorexia. 5th Cachexia Conference, Barcelona, Spain 2009.
164. Ren S.G., Seliktar J., Li X., Braunstein G.D., Melmed S. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. J Clin Endocrinol Metab 1998, 83:1275-1283.
165. Gouin F., Heymann D., Raher S., De Groote D., Passuti N., Daculsi G., et al. Increased levels of leukaemia inhibitory factor (LIF) in urine and tissue culture supernatant from human primary bone tumours. Cytokine 1998, 10:110-114.
166. Lorgeot V., Praloran V., Turlure P., Denizot Y. Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies. Leukemia 1997, 11:311-312.
167. Villers D., Dao T., Nguyen J.M., Bironneau E., Godard A., Moreau M., et al. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J Infect Dis 1995, 171:232-236.
168. Carlson C.D., Bai Y., Jonakait G.M., Hart R.P. Interleukin-1 beta increases leukemia inhibitory factor mRNA levels through transient stimulation of transcription rate. Glia 1996, 18:141-151.
169. Gayle D., Ilyin S.E., Flynn M.C., Plata-Salamán C.R. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res 1998, 795:77-86.
170. Metcalf D., Gearing D.P. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 1989, 86:5948-5952.
171. Beretta E., Dhillon H., Kalra P.S., Kalra S.P. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides 2002, 23:975-984.
172. Mori M., Yamaguchi K., Honda S., Nagasaki K., Ueda M., Abe O., et al.
173. Ray D.W., Ren S.G., Melmed S. Leukemia inhibitory factor regulates proopiomelanocortin transcription. Ann N Y Acad Sci 1998, 840:162-173.
174. Ray D.W., Ren S.G., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 1996, 97:1852-1859.
175. Swan J.W., Anker S.D., Walton C., Godsland I.F., Clark A.L., Leyva F., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997, 30:527-532.
176. Doehner W., Rauchhaus M., Ponikowski P., Godsland I.F., von Haehling S., Okonko D.O., et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005, 46:1019-1026.
177. Parton L.E., Ye C.P., Coppari R., Enriori P.J., Choi B., Zhang C.-Y., et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007, 449:228-232.
178. Coppari R., Ichinose M., Lee C.E., Pullen A.E., Kenny C.D., McGovern R.A., et al. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005, 1:63-72.
179. Minokoshi Y., Alquier T., Furukawa N., Kim Y.-B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
180. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007, 117:3475-3488.
181. Howard J.K., Cave B.J., Oksanen L.J., Tzameli I., Bjørbaek C., Flier J.S. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004, 10:734-738.
182. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995, 20:111-116.
183. Capuron L., Ravaud A., Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 2000, 18:2143-2151.
184. Myint A.M., Schwarz M.J., Steinbusch H.W.M., Leonard B.E. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis 2009, 24:55-68.
185. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 1999, 461:199-233.
186. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res 1996, 711:163-174.
187. Maier S.F., Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 1995, 695:279-282.
188. Hsu R., Taylor J.R., Newton S.S., Alvaro J.D., Haile C., Han G., et al. Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci 2005, 21:2233-2242.
189. Lindblom J., Kask A., Hägg E., Härmark L., Bergström L., Wikberg J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 2002, 45:119-124.
190. Lindblom J., Opmane B., Mutulis F., Mutule I., Petrovska R., Klusa V., et al. The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. Neuroreport 2001, 12:2155-2158.
191. Tatro J.B., Entwistle M.L. Distribution of melanocortin receptors in the lower brainstem of the rat. Ann N Y Acad Sci 1994, 739:311-314.
192. Kawashima N., Chaki S., Okuyama S. Electrophysiological effects of melanocortin receptor ligands on neuronal activities of monoaminergic neurons in rats. Neurosci Lett 2003, 353:119-122.
193. Holmes J.E., Miller N.E. Effects of bacterial endotoxin on water intake, food intake and body temperature in the albino rat. J Exp Med 1963, 118:649-658.
194. Kozak W., Conn C.A., Kluger M.J. Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am J Physiol 1994, 266:R125-R135.
195. Mesaros A., Koralov S.B., Rother E., Wunderlich F.T., Ernst M.B., Barsh G.S., et al. Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab 2008, 7:236-248.
196. Huo L., Gamber K., Greeley S., Silva J., Huntoon N., Leng X.-H., et al. Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab 2009, 9:537-547.
197. Dandona P., Dhindsa S., Chaudhuri A., Bhatia V., Topiwala S., Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med 2008, 8:816-828.
198. Shabanova S.S., Ananieva L.P., Alekberova Z.S., Guzov I.I. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2008, 26:436-441.
199. Tengstrand B., Carlström K., Hafström I. Gonadal hormones in men with rheumatoid arthritis-from onset through 2years. J Rheumatol 2009, 36:887-892.
200. Reynoso R., Ponzo O., Cardoso N., Szwarcfarb B., Carbone S., Moguilevsky J., et al. Effect of bacterial lipopolysaccharide on the reproductive axis of prepubertal and peripubertal female rats. Ontogenic changes in the immune-neuroendocrine interactions. Neuroimmunomodulation 2008, 15:125-130.
201. Kalra P.S., Sahu A., Kalra S.P. Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. Endocrinology 1990, 126:2145-2152.
202. Schiöth H.B., Watanobe H. Melanocortins and reproduction. Brain Res Brain Res Rev 2002, 38:340-350.
203. Backholer K., Smith J., Clarke I. Melanocortins may stimulate reproduction by activating orexin neurons in the dorsomedial hypothalamus and kisspeptin neurons in the preoptic area of the ewe. Endocrinology 2009, 150:5488-5497.